Projects per year
Personal profile
Personal Statement
I obtained a pharmacy degree from the University of Strathclyde in 1979 followed by a PhD in Physiochemical Aspects of Anti-Cancer Drug Targeting Systems in 1984. I worked during pre-registration in industrial and hospital pharmacy settings, joined SIPBS as a lecturer in 1984 and was appointed Director of the Formulation Unit in 1992. The Unit's role is to characterise, analyse, formulate and manufacture putative anti-cancer drugs accepted by CRUK's New Agents Committee for use in human clinical trials, where I have now been pharmaceutically responsible for over 20 novel NCE's. Arising from this are research interests, which include medicinal and analytical chemistry, drug physiochemistry, formulation for both small volume and parenteral and oral products and the GMP production of specialist pharmaceutical products for phase l clinical trials. The latter incorporates research areas such as microbiology and lyophilisation. In addition related research is conducted in drug targeting and delivery systems for cancer chemotherapy for example the utilisation of synthetic Low Density Lipoprotein systems. I have over £10 million in personal career grant income and over 150 published papers, conference abstracts and presentations.
Undergraduate teaching is limited due to the nature of the Formulation Unit's activities to introductory and specialist courses associated with the areas above applicable to undergraduate pharmacists. Since 1987 I have been involved in post qualification education teaching for the pharmaceutical industry and initiated and teach on the joint SIPBS-David Begg Associates Qualified Persons training course which has been running since 1991.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Network
-
KTP - Target Healthcare Limited. Development of platform capability and creation of a robust framework for the assessment of shelf life and stability of a range of aseptically prepared Monoclonal Anti-Bodies (MABs) for patient use.
Target Healthcare Limited, Innovate UK
24/10/22 → 23/10/24
Project: Research
-
Doctoral Training Partnership 2020-2021 University of Strathclyde | Ugorenko, Agata
Perrie, Y., Halbert, G. & Ugorenko, A.
EPSRC (Engineering and Physical Sciences Research Council)
1/10/21 → 1/04/25
Project: Research Studentship - Internally Allocated
-
Development and implementation of a pneumatic micro-feeder for poorly-flowing solid pharmaceutical materials
Hou, P., Besenhard, M. O., Halbert, G., Naftaly, M. & Markl, D., 25 Mar 2023, In: International Journal of Pharmaceutics. 635, 15 p., 122691.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Downloads (Pure) -
Acidic drugs - intestinal solubility correlation fasted and fed in vitro vs ex vivo
Halbert, G., Inês Silva, M., Abuhassan, Q., Khadra, I., Pyper, K., Augustijns, P. & Brouwer, J., 23 Mar 2023. 2 p.Research output: Contribution to conference › Abstract › peer-review
Open AccessFile5 Downloads (Pure)
Datasets
-
Data for: "Manufacturing considerations for the development of lipid nanoparticles using microfluidics"
Roces Rodriguez, C. B. (Creator), Perrie, Y. (Creator) & Halbert, G. (Contributor), University of Strathclyde, 26 Nov 2020
DOI: 10.15129/32db8191-3d6f-4d44-ade0-72c285f82a99
Dataset
-
Data for: "Mefenamic acid solid dispersions: Impact of formulation composition on processing parameters, product properties and performance"
Prasad, E. (Creator), Robertson, J. (Contributor) & Halbert, G. (Contributor), University of Strathclyde, 25 Oct 2021
DOI: 10.15129/8597108f-6daa-43e1-8d2d-796b97c36f3a
Dataset
Activities
-
Opening up the pharmaceutical formulation space for Additive Manufacturing
Elke Prasad (Speaker), John Robertson (Contributor) & Gavin Halbert (Contributor)
6 Oct 2021Activity: Talk or presentation types › Oral presentation
-
ToF-SIMS imaging of amorphous solid dispersions: a stability study
Eleonora Paladino (Speaker), Frederik Doerr (Contributor), Iyke I. Onyemelukwe (Contributor), Ian Gilmore (Contributor) & Gavin Halbert (Contributor)
23 Oct 2019Activity: Talk or presentation types › Oral presentation
Impacts
-
Improved health and survival rates for patients with malignant brain and prostate cancer, and economic benefit from new chemotherapy treatments.
Gavin Halbert (Participant)
Impact: Impact - for External Portal › Economic and commerce, Health and welfare - new products, guidelines and services
File
Equipment
-
Agilent 1290 Infinity HPLC 10
Strathclyde Institute Of Pharmacy And Biomedical SciencesFacility/equipment: Equipment
-
Agilent 1290 Infinity HPLC 11
Strathclyde Institute Of Pharmacy And Biomedical SciencesFacility/equipment: Equipment